STOCK TITAN

GMRBV Financials

GMRBV
Trailing 12 months to March 31, 2026
Revenue $151.7M +9.7% YoY
Net Income -$9.0M -210.5% YoY
EPS (Diluted) -$0.91 FY2025 annual
Operating Cash Flow $74.7M +9.8% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GMRBV SEC filings page.

GMRBV (GMRBV) reported $151.7M in revenue over the twelve months to Mar 31, 2026, up 9.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GMRBV FY2025

The dominant mechanic is an asset-heavy balance sheet where accounting earnings weakened while operating cash stayed positive through noncash depreciation.

2025’s loss of -$6.9M coexisted with operating cash flow of $73.6M, alongside $58.0M of depreciation and amortization; that gap is consistent with reported profit being heavily affected by noncash asset charges. Yet investing outflow reached $60.4M, and free cash flow is unreported, so operating cash is not demonstrably surplus cash.

With $1.24B of assets against $148.2M of FY2025 revenue, the business carries an asset base roughly 8.4x revenue. That makes the -0.6% ROA especially informative: the capital base is producing little accounting return.

Revenue was higher in FY2025, yet net income moved from a $6.7M profit to a -$6.9M loss; growth did not translate into earnings. The net-margin swing from 4.8% to -4.6% indicates a profitability break rather than merely a change in share count.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

GMRBV does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
5/7

GMRBV passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

GMRBV reported a net loss of $6.9M while generating $73.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$38.1M
YoY+10.0%
QoQ-0.9%
5Y CAGR+6.8%
10Y CAGR+40.0%

GMRBV generated $38.1M in revenue in Q1 2026. This represents an increase of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Net Income
$1.7M
YoY-55.7%
QoQ+126.9%
5Y CAGR-13.0%

GMRBV reported $1.7M in net income in Q1 2026. This represents a decrease of 55.7% from the same quarter a year earlier. Against the prior quarter it is up 126.9%.

EPS (Diluted)
-$0.06

GMRBV earned -$0.06 per diluted share (EPS) in Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt
$8.2M
YoY+51.2%
QoQ-9.9%
5Y CAGR+9.1%
10Y CAGR+32.1%

GMRBV held $8.2M in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding
13M
QoQ0.0%
5Y CAGR-24.0%
10Y CAGR+25.0%

GMRBV had 13M shares outstanding in Q1 2026. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Net Margin
4.3%
YoY-6.4pp
QoQ+20.4pp
5Y change-7.8pp

GMRBV's net profit margin was 4.3% in Q1 2026, showing the share of revenue converted to profit. This is down 6.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.4 percentage points.

Return on Equity
0.3%
YoY-0.4pp
QoQ+1.5pp
5Y change-0.2pp
10Y change+15.6pp

GMRBV's ROE was 0.3% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

GMRBV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GMRBV quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$38.1M+10.0%$38.4M+9.2%$37.2M+8.7%$38.0M+10.9%$34.6M-1.4%$35.2M+6.7%$34.3M-3.5%$34.2M-5.8%
SG&A Expenses$5.1M+40.6%$5.5M-28.7%$4.9M+10.9%$6.0M+31.3%$3.6M-18.6%$7.7M+82.6%$4.4M+0.3%$4.6M+2.8%
Interest Expense$7.2M+0.9%$8.4M+11.0%$8.2M+13.0%$8.0M+14.5%$7.2M+4.0%$7.6M+8.4%$7.2M+0.9%$7.0M-17.4%
Net Income$1.7M-55.7%-$6.1M-309.2%-$5.1M-249.2%$585K+130.0%$3.7M+61.5%$2.9M+433.4%$3.4M-29.8%-$2.0M-113.8%
EPS (Basic)-$0.06-137.5%N/A-$0.45-421.4%-$0.01+80.0%$0.16+1500.0%N/A$0.14+180.0%-$0.05-127.8%
EPS (Diluted)-$0.06N/A-$0.45-$0.01+80.0%$0.16N/A$0.14-$0.05
Diluted Shares (Avg)13MN/A13M67M+2.0%13MN/A13M66M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax.

GMRBV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GMRBV quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Total Assets$1.2B-2.5%$1.2B-1.1%$1.3B+2.5%$1.3B+4.5%$1.3B+0.5%$1.3B-0.9%$1.2B-4.6%$1.2B-6.0%
Cash & Equivalents$8.2M+51.2%$9.1M+33.3%$7.1M+24.5%$6.6M+32.2%$5.4M+306.0%$6.8M+433.3%$5.7M+346.8%$5.0M+102.4%
Accounts Receivable$6.8M-16.1%$7.2M-2.7%$7.9M-2.2%$7.8M-3.1%$8.1M+4.7%$7.4M+9.8%$8.1M+7.9%$8.1M+9.4%
Goodwill$5.9M0.0%$5.9M0.0%$5.9M0.0%$5.9M0.0%$5.9M0.0%$5.9M0.0%$5.9M0.0%$5.9M0.0%
Total Liabilities$717.4M-1.9%$712.4M+1.7%$767.4M+13.2%$771.9M+16.5%$731.5M+9.7%$700.6M+5.8%$678.0M+1.4%$662.8M-2.4%
Long-Term DebtN/A$1.2M-92.0%$1.2M-92.1%$14.2M-3.5%$14.3M-44.6%$14.4M$14.5M$14.7M
Total Equity$500.2M-3.3%$509.8M-4.6%$485.3M-10.6%$503.2M-9.6%$517.4M-10.0%$534.1M-8.5%$542.6M-11.3%$556.4M-10.2%
Retained Earnings-$360.6M-18.0%-$350.0M-19.1%-$332.6M-18.3%-$316.5M-17.7%-$305.7M-21.3%-$293.7M-22.9%-$281.1M-25.3%-$268.9M-25.8%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

GMRBV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GMRBV quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Operating Cash Flow$13.4M+8.8%$21.6M+5.4%$17.6M+7.8%$22.1M+17.0%$12.3M-14.1%$20.5M+13.2%$16.3M-2.2%$18.9M+5.9%
Depreciation & Amortization$14.5M+6.7%$21.9M+5.3%$11.2M+12.2%$11.3M+11.7%$13.6M-2.7%$20.8M-7.6%$10.0M-1.1%$10.1M-3.3%
Stock-Based Compensation$1.2M+713.9%N/A$1.2M-5.3%$1.7M+31.0%$151K-87.8%N/A$1.3M+7.5%$1.3M+15.0%
Investing Cash Flow-$9.8M+63.8%$6.7M+134.6%-$703K+97.2%-$39.2M-2297.5%-$27.2M-902.4%-$19.5M-526.9%-$25.5M-550.0%$1.8M-97.1%
Financing Cash Flow-$4.4M-132.6%-$26.3M-17310.5%-$16.2M-277.4%$18.7M+190.4%$13.6M+229.6%$153K+101.0%$9.2M+137.4%-$20.7M+75.4%
Dividends Paid$10.9M+651.8%$1.5M0.0%$1.5M0.0%$1.5M0.0%$1.5M0.0%$1.5M0.0%$1.5M0.0%$1.5M0.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.

GMRBV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GMRBV quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Net Margin4.3%-6.4pp-16.0%-24.4pp-13.6%-23.5pp1.5%+7.2pp10.8%+4.2pp8.4%+6.7pp9.9%-3.7pp-5.7%-44.7pp
Return on Equity0.3%-0.4pp-1.2%-1.8pp-1.0%-1.7pp0.1%+0.5pp0.7%+0.3pp0.5%+0.5pp0.6%-0.2pp-0.4%-2.6pp
Return on Assets0.1%-0.2pp-0.5%-0.7pp-0.4%-0.7pp0.1%+0.2pp0.3%+0.1pp0.2%+0.2pp0.3%-0.1pp-0.2%-1.2pp
Debt-to-Equity1.43+1.4x0.000.0x0.000.0x0.030.0x0.030.0x0.03-1.1x0.03-1.1x0.03-1.1x
Asset Turnover0.030.0x0.030.0x0.030.0x0.030.0x0.030.0x0.030.0x0.030.0x0.030.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Frequently Asked Questions

What is GMRBV's annual revenue?

GMRBV (GMRBV) reported $148.2M in total revenue for fiscal year 2025. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is GMRBV's revenue growing?

GMRBV (GMRBV) revenue grew by 6.8% year-over-year, from $138.8M to $148.2M in fiscal year 2025.

Is GMRBV profitable?

No, GMRBV (GMRBV) reported a net income of -$6.9M in fiscal year 2025, with a net profit margin of -4.6%.

GMRBV (GMRBV) reported diluted earnings per share of -$0.91 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, GMRBV (GMRBV) had $9.1M in cash and equivalents against $1.2M in long-term debt.

GMRBV (GMRBV) had a net profit margin of -4.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

GMRBV (GMRBV) has a return on equity of -1.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

GMRBV (GMRBV) generated $73.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

GMRBV (GMRBV) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, GMRBV (GMRBV) spent $6.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

GMRBV (GMRBV) had 13M shares outstanding as of fiscal year 2025.

GMRBV (GMRBV) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

GMRBV (GMRBV) had a return on assets of -0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

GMRBV (GMRBV) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

GMRBV (GMRBV) reported a net loss of $6.9M while generating $73.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top